Quick answer
What does a homocysteine result mean?
Total homocysteine is a metabolic clue, not a diagnosis or a universal heart-risk target. Many laboratories use an adult interval around 5–15 µmol/L, but the interval printed on the report takes priority because method, age, sex, pregnancy, kidney function and sample handling matter. A high result can occur with vitamin B12 or folate deficiency, reduced kidney function, hypothyroidism, medicines, smoking or an inherited metabolic disorder. It does not reveal the cause by itself, and lowering the number has not consistently prevented heart attack, dementia or death in trials.See reference 1,See reference 2,See reference 3,See reference 4,See reference 13
Six points that prevent most homocysteine mistakes
- Use the laboratory's own interval. About 5–15 µmol/L is a common adult reference interval, not one worldwide ‘optimal’ longevity range.See reference 3,See reference 4
- Collection matters: blood cells continue releasing homocysteine after the draw. Delayed cooling and plasma separation can falsely raise the result.See reference 2,See reference 3,See reference 4
- High homocysteine does not prove a B12, folate or B6 deficiency. B12, methylmalonic acid, folate, kidney function, thyroid context, medicines and symptoms help separate causes.See reference 1,See reference 3,See reference 7,See reference 9,See reference 10
- A common MTHFR variant is not ‘methylation disease’ and does not automatically require methylfolate, a special dose or genetic testing.See reference 8
- Higher homocysteine is associated with vascular, cognitive, bone and pregnancy outcomes, but association does not prove causation. Trials do not support a blanket supplement promise.See reference 13,See reference 14,See reference 15,See reference 16
- Very high results—especially in the tens to hundreds with young thrombosis, eye, skeletal, developmental or neurological features—need clinician-led metabolic assessment, not an online diagnosis.See reference 5,See reference 6,See reference 7
What total homocysteine measures—and what it cannot tell you
Homocysteine is a sulfur-containing amino-acid intermediate made during methionine metabolism. It can be recycled to methionine through folate- and vitamin-B12-dependent reactions, or moved toward cysteine through a vitamin-B6-dependent pathway. The routine laboratory result is total homocysteine, which combines free, protein-bound and disulfide forms after laboratory reduction.See reference 1,See reference 6,See reference 7
The result can help investigate vitamin B12 or folate deficiency, suspected inherited methionine or cobalamin disorders, and selected clinical problems. It is not recommended as a routine stand-alone cardiovascular screen for every healthy person, and it cannot identify a vitamin deficiency, gene variant or vascular disease by itself.See reference 1,See reference 3,See reference 13,See reference 14
A normal result does not exclude every case of B12 deficiency, and a high result is not specific to B12. This is why the useful question is not only ‘How high is it?’ but also ‘Was the sample handled correctly, and what do the related results and clinical history show?’See reference 1,See reference 7,See reference 9,See reference 10
Before interpreting the number, check how the sample was collected
| Issue | Why it matters | Practical interpretation |
|---|---|---|
| EDTA plasma versus serum | EDTA plasma is preferred in many protocols. Cells continue releasing homocysteine while serum clots and while whole blood remains unseparated. | Use the specimen and interval stated by the performing laboratory; do not combine plasma and serum ranges casually.See reference 2,See reference 3,See reference 4 |
| Cooling and prompt separation | Unseparated cells can make homocysteine rise after the draw. CDC's reference protocol keeps blood cold and harvests plasma within 30 minutes; local laboratories may validate a different window. | An unexpected high result from a delayed or warm sample may need confirmation under the laboratory's correct handling protocol.See reference 2 |
| Fasting | Fasting is commonly preferred because meals and methionine intake can influence the value, but laboratories and clinical purposes differ. | Follow the ordering laboratory's instructions. A nonfasting result is not automatically invalid.See reference 2,See reference 4 |
| Repeat testing | Within-person variation and changing diet, supplements, illness, kidney or thyroid status can move the result. | For an unexpected result, compare the same laboratory, method, preparation and stable clinical state when practical.See reference 3,See reference 17 |
Reference interval, descriptive severity and inherited disease are different concepts
| Result context | What it may mean | What it does not mean |
|---|---|---|
| About 5–15 µmol/L in many adult laboratories | An illustrative population reference interval. The report's own interval controls. | It is not a universal optimal target or proof that every value inside it carries identical risk.See reference 3,See reference 4 |
| Roughly 15–30 µmol/L | Often described as a mild or moderate elevation. Recheck handling and evaluate common acquired causes in context. | It does not diagnose vitamin deficiency, MTHFR disease or cardiovascular disease.See reference 1,See reference 3,See reference 4,See reference 22 |
| Roughly 30–100 µmol/L | A more substantial elevation that merits timely clinician-led evaluation for acquired and inherited causes. | The category name and boundary vary; the number alone does not identify the cause.See reference 5,See reference 6,See reference 7,See reference 22 |
| Above 100 µmol/L, or lower with suggestive features | Can occur in classical CBS deficiency and other serious metabolic disorders; methionine, MMA and clinical features help distinguish pathways. | It is not a stand-alone diagnosis of homocystinuria. Milder inherited disease can occur below 100 µmol/L.See reference 5,See reference 6,See reference 7 |
There is no single evidence-based ‘optimal homocysteine’ number
A laboratory reference interval describes the distribution produced by a specific method and reference population. A disease-work-up threshold identifies a level or pattern that may need urgent specialist investigation. An epidemiological risk association compares groups. These are not interchangeable targets.See reference 3,See reference 4,See reference 5,See reference 13
Some sources promote a value below 10 µmol/L as universally optimal. Randomized trials have not established that target for healthy adults, and routinely lowering homocysteine has not reduced myocardial infarction or all-cause death. Treat documented causes and overall risk rather than chasing an unsupported internet target.See reference 13,See reference 14
Age, sex, menopause, pregnancy, kidney function, thyroid status, smoking, nutrition, medicines, folate fortification and the assay all change context. Serial comparisons are clearest when the laboratory and preparation remain consistent.See reference 1,See reference 3,See reference 4,See reference 16,See reference 17
The unit label can change while the number stays the same
One µmol/L is numerically equal to one nmol/mL, so 12.0 µmol/L is 12.0 nmol/mL. This identity changes only the unit label. A result in mmol/L is 1,000 times larger than the same number in µmol/L, so never remove or guess the unit.See reference 2,See reference 3
The helper runs only in this browser, masks the input and sends no value for interpretation. It does not classify a result, diagnose a deficiency or inherited disorder, estimate cardiovascular risk, set an optimal target, store a value or recommend a supplement.See reference 3,See reference 4,See reference 5
Common reasons homocysteine can be high
| Possible contributor | Useful context | Important limit |
|---|---|---|
| Vitamin B12 or folate deficiency; sometimes B6 or riboflavin deficiency | Review B12, MMA, folate, diet, absorption, supplements, blood count and symptoms. | Homocysteine cannot identify which vitamin is deficient and may be normal in some B12 deficiency.See reference 1,See reference 7,See reference 9,See reference 10,See reference 11 |
| Reduced kidney function or hypothyroidism | Creatinine/eGFR and clinically appropriate thyroid testing can change the interpretation. | A high value in chronic kidney disease is not proof of vitamin deficiency or vascular causality.See reference 1,See reference 3,See reference 7 |
| Older age, menopause, smoking, alcohol use disorder, malnutrition or malabsorption | The pattern, nutrition history and wider clinical picture matter more than one isolated cause list. | Association does not establish the cause in an individual.See reference 1,See reference 3 |
| Medicines including methotrexate, metformin, some anticonvulsants, sulfasalazine and levodopa | Review indication, timing, nutrition and related tests with the prescriber or pharmacist. | Never stop or change a medicine because of an online interpretation.See reference 1,See reference 3,See reference 18 |
| Rare CBS or remethylation disorders; common MTHFR variants | Very high results and suggestive features need specialist testing; common variants usually have a much smaller effect influenced by folate status. | A common MTHFR result is not a diagnosis of homocystinuria or ‘methylation disease’.See reference 5,See reference 6,See reference 7,See reference 8 |
| Delayed cooling or cell separation | Check specimen type, collection time and the laboratory's processing record when the result is unexpected. | Pre-analytical elevation is not a biological disease signal.See reference 2,See reference 3,See reference 4 |
What high homocysteine is associated with—and what treatment trials show
| Question | What the evidence shows | Responsible conclusion |
|---|---|---|
| Heart attack and stroke | Observational studies associate higher levels with vascular events. In a Cochrane review of 15 trials and 71,422 participants, B-vitamin lowering did not reduce myocardial infarction or all-cause death; stroke was modestly lower, with important population and fortification caveats. | Do not promise cardiovascular prevention from a lower number or routine supplements. Manage proven risk factors and treat documented deficiency.See reference 13,See reference 14 |
| Cognition and dementia | Higher levels are associated with cognitive decline and dementia, but a large-trial meta-analysis found B vitamins lowered homocysteine without improving global cognition or cognitive ageing. | A high result does not diagnose dementia, and lowering it is not established dementia prevention.See reference 15 |
| Pregnancy outcomes | Higher maternal levels are associated with pre-eclampsia, growth restriction, preterm birth and pregnancy loss in heterogeneous observational studies; pregnancy levels normally change by trimester. | It is not a stand-alone pregnancy screen or treatment target. Folic-acid neural-tube prevention follows public-health guidance, not a homocysteine target.See reference 12,See reference 16,See reference 21 |
| Bone and fracture | Observational reviews associate higher homocysteine with fracture and bone-quality measures. | B-vitamin lowering has not established fracture prevention, so do not treat the marker as a bone diagnosis.See reference 19 |
Lowering the laboratory number is not the same as improving health outcomes
Correcting confirmed B12, folate or B6 deficiency is evidence-based care because the deficiency itself matters. That is different from giving a high-dose B-complex to every person with a mildly high homocysteine result. The cause, baseline nutrition, folate-fortification setting, kidney function, medicine exposure and clinical purpose change the balance.See reference 9,See reference 10,See reference 11,See reference 13
Folic acid plus blood-pressure treatment reduced first stroke in a specific Chinese hypertensive population without broad folate fortification. That result should not be generalized automatically to folate-fortified countries, people with adequate folate or a different treatment regimen.See reference 20
Betaine can lower homocysteine in selected inherited metabolic disorders, but it can alter methionine and requires specialist dosing and monitoring. It is not a general longevity supplement or a self-treatment for one mildly high result.See reference 5,See reference 6,See reference 7
What a low homocysteine result usually means
Low homocysteine is usually not treated as an adverse finding. It can occur with adequate or high folate/B-vitamin intake, lower methionine or protein intake, pregnancy physiology or uncommon metabolic states. The reporting laboratory and clinical context still matter.See reference 1,See reference 3,See reference 16
A low number does not prove ‘under-methylation’, glutathione depletion or poor detoxification. Those popular interpretations are not validated clinical uses of the test. Do not add methionine or change protein intake solely to move the number upward.See reference 1,See reference 3
MTHFR is often overinterpreted
Common MTHFR C677T and A1298C variants can influence folate metabolism and may shift homocysteine, especially when folate intake is low. They are common variants, not a diagnosis of an inherited homocystinuria or remethylation disorder.See reference 8
MedlinePlus notes that treatment for a high homocysteine result is generally the same whether or not a common MTHFR variant is present. A variant does not automatically require methylfolate, high-dose supplements, a restrictive diet or repeated gene testing. Evaluate the measurable result, vitamin status, kidney function and clinical reason for testing.See reference 8
Do not treat a high result with folate alone before checking B12
High supplemental folate can correct the anaemia of vitamin B12 deficiency while neurological injury continues. B12-related nerve damage can occur without anaemia and may become permanent. Chronic high-dose vitamin B6 can itself cause sensory neuropathy; authorities also use different upper limits. New or worsening numbness, weakness, balance, walking, vision or cognitive symptoms need prompt clinical assessment. Do not use a B-complex, methylfolate, B6 or betaine dose from an online homocysteine chart.See reference 9,See reference 10,See reference 11
When a result or symptom pattern needs faster assessment
Seek urgent care for possible blood clot, stroke or heart symptoms such as one-sided weakness, trouble speaking, sudden severe shortness of breath, coughing blood or severe chest pain; a homocysteine value alone cannot triage an emergency. Arrange prompt clinician-led evaluation for a result in the tens to hundreds, especially with thrombosis at a young age, lens dislocation or marked vision change, unusual skeletal features, developmental concerns, seizures or progressive neurological symptoms. A repeat blood test should not delay emergency assessment.See reference 5,See reference 6,See reference 7
Pregnancy needs a different interpretation
Homocysteine commonly falls during pregnancy and varies by trimester, so a nonpregnant adult interval should not be applied automatically. Observational links with pre-eclampsia, fetal growth, preterm birth and pregnancy loss are heterogeneous and do not make the result a stand-alone diagnosis or treatment target.See reference 16,See reference 21
For neural-tube prevention, CDC recommends 400 µg of folic acid daily for people capable of pregnancy before conception and during early pregnancy. This is a public-health folic-acid recommendation—not proof that an MTHFR test, methylfolate product or particular homocysteine number prevents a complication. Higher-risk prescriptions and any abnormal pregnancy result need obstetric guidance.See reference 12
Common claims that go beyond the evidence
| Claim | More accurate interpretation |
|---|---|
| Everyone should be below 10 µmol/L. | No universal optimal target is established. Use the laboratory interval, reason for testing, related results and proven clinical risk factors.See reference 3,See reference 4,See reference 13 |
| High homocysteine means it is causing heart disease. | The association is real, but causation and benefit from routine lowering are not established uniformly. One value does not diagnose vascular disease.See reference 13,See reference 14 |
| A high result proves B12 deficiency. | B12, folate, B6, kidney, thyroid, medicines, lifestyle, genetics and sample handling can all contribute.See reference 1,See reference 3,See reference 7 |
| An MTHFR variant means I need methylfolate. | Common variants do not automatically require genotyping, methylfolate or a special dose. Treat documented problems in context.See reference 8 |
| Lower is always better. | Low values are usually not concerning, but the test is not a score to minimize. Outcome trials do not support chasing the lowest possible number.See reference 1,See reference 13 |
See homocysteine beside the results that give it context
Upload an existing report to organize homocysteine with vitamin B12, methylmalonic acid, folate, blood count and MCV, creatinine/eGFR and thyroid results where present. LongevityMate helps you see the pattern and prepare questions to discuss—it does not diagnose a vitamin or inherited disorder, calculate cardiovascular risk, choose an MTHFR treatment or prescribe supplements.
Upload my blood-test resultsQuestions people ask about homocysteine results
What is a normal homocysteine level?
Many adult laboratories use an interval around 5–15 µmol/L, but the interval printed on your report takes priority. Method, specimen, sample handling, age, sex, pregnancy and kidney function can change interpretation. This is a reference interval, not a universal optimal longevity target.See reference 3,See reference 4
Is 15 or 20 µmol/L high?
It is above the upper limit used by many laboratories and is often described as a mild or moderate elevation, but use your report's own interval. Check collection handling, B12 and folate context, kidney and thyroid status, medicines, supplements and whether repeat testing is appropriate. It does not diagnose the cause or heart disease.See reference 1,See reference 2,See reference 3,See reference 4
Do I need to fast for a homocysteine test?
Fasting is commonly preferred because meals and methionine intake can influence the value, but laboratory protocols differ. Follow the ordering laboratory's instructions and do not call a nonfasting result invalid without checking the method and purpose. Prompt cooling and cell separation can matter more than a generic fasting rule.See reference 2,See reference 4
Why must the homocysteine sample be separated quickly?
Blood cells continue releasing homocysteine after collection, so unseparated room-temperature blood can produce a falsely high result. CDC's reference protocol keeps EDTA blood cold and harvests plasma within 30 minutes; the performing laboratory may have its own validated window.See reference 2
Does high homocysteine prove B12 deficiency?
No. B12 and folate deficiency are common causes, but B6 or riboflavin deficiency, kidney impairment, hypothyroidism, medicines, smoking, alcohol use disorder, genetics and delayed sample processing can also contribute. B12, MMA, folate, creatinine/eGFR and clinical context help separate patterns.See reference 1,See reference 2,See reference 3,See reference 7,See reference 9,See reference 10,See reference 11
Does MTHFR mean I need methylfolate?
No. Common MTHFR variants can modestly influence homocysteine, especially with low folate, but they do not diagnose methylation disease or automatically require methylfolate, high doses or genetic testing. MedlinePlus says treatment for a high result is generally the same with or without a common MTHFR variant.See reference 8
Does lowering homocysteine prevent heart attack, stroke or dementia?
Not reliably. A large Cochrane review found no reduction in myocardial infarction or all-cause death; stroke was modestly lower, but results vary by folate fortification, baseline status, population and regimen. A large-trial cognitive meta-analysis found lower homocysteine without better global cognition. Treat documented deficiencies and proven risk factors rather than assuming a lower marker guarantees benefit.See reference 13,See reference 14,See reference 15
Can kidney disease or hypothyroidism raise homocysteine?
Yes. Reduced kidney function is a common confounder, and hypothyroidism is associated with higher values. A high result in chronic kidney disease does not prove vitamin deficiency or vascular causality, and thyroid testing is guided by the wider clinical picture rather than ordered automatically for every small elevation.See reference 1,See reference 3,See reference 7
Can folic acid hide vitamin B12 deficiency?
High supplemental folate can correct the anaemia of B12 deficiency while neurological injury continues. B12 nerve injury can occur without anaemia. Check and treat possible B12 deficiency rather than using folate alone to chase homocysteine; new numbness, weakness, balance or cognitive symptoms need prompt assessment.See reference 9,See reference 10
Can high-dose vitamin B6 cause nerve damage?
Yes. Chronic excessive supplemental B6 can cause sensory neuropathy. U.S. and European authorities use different adult upper limits, which is one reason not to self-prescribe a high-dose B-complex from a homocysteine result.See reference 11
What is the difference between high homocysteine and homocystinuria?
High homocysteine is a laboratory finding with many acquired causes. Homocystinuria describes rare inherited metabolic disorders. Classical untreated CBS deficiency often produces values above 100 µmol/L, but milder adult disease can be lower. Methionine, MMA, symptoms and confirmatory biochemical or genetic tests are required; one homocysteine result cannot diagnose it.See reference 5,See reference 6,See reference 7
What does a low homocysteine result mean?
Low homocysteine is usually not treated as an adverse finding. It may reflect adequate or high B-vitamin intake, lower methionine intake or pregnancy physiology. It does not prove under-methylation, poor detoxification or glutathione depletion, and it is not a number to raise without a clinical reason.See reference 1,See reference 3,See reference 16,See reference 21
References
- 1. Homocysteine Test
MedlinePlus, U.S. National Library of MedicineOfficial guidance
- 2. Laboratory Procedure Manual: Total Homocysteine in Plasma
U.S. Centers for Disease Control and Prevention, NHANESOfficial guidance
- 3. Homocysteine, Total, Serum (HCYSS)
Mayo Clinic LaboratoriesOfficial guidance
- 4. Homocysteine — Pathology Test Information
South Tees Hospitals NHS Foundation TrustOfficial guidance
- 5. Homocystinuria Due to Cystathionine Beta-Synthase Deficiency — Diagnostic Homocysteine and Methionine Patterns
GeneReviews, National Center for Biotechnology InformationEvidence review
- 6. Guidelines for the Diagnosis and Management of Cystathionine Beta-Synthase Deficiency
Journal of Inherited Metabolic DiseaseGuideline
- 7. Guidelines for the Diagnosis and Management of the Cobalamin-Related Remethylation Disorders
Journal of Inherited Metabolic DiseaseGuideline
- 8. MTHFR Gene Test
MedlinePlus, U.S. National Library of MedicineOfficial guidance
- 9. Folate — Health Professional Fact Sheet
NIH Office of Dietary SupplementsOfficial guidance
- 10. Vitamin B12 — Health Professional Fact Sheet
NIH Office of Dietary SupplementsOfficial guidance
- 11. Vitamin B6 — Health Professional Fact Sheet
NIH Office of Dietary SupplementsOfficial guidance
- 12. About Neural Tube Defects and Folic Acid Prevention
U.S. Centers for Disease Control and PreventionOfficial guidance
- 13. Homocysteine-Lowering Interventions for Preventing Cardiovascular Events
CochraneSystematic review
- 14. 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
American Heart Association and American Stroke AssociationGuideline
- 15. Effects of Homocysteine Lowering With B Vitamins on Cognitive Aging: Meta-Analysis of 11 Trials With 22,000 Individuals
American Journal of Clinical NutritionMeta-analysis
- 16. Maternal Homocysteine During Pregnancy: Reference Change and Outcome Evidence
Laboratory MedicineObservational study
- 17. Week-to-Week Biological Variation of Plasma Homocysteine in Healthy Women
Clinical Chemistry and Laboratory MedicineObservational study
- 18. Drugs and Homocysteine Metabolism
Current Drug MetabolismEvidence review
- 19. Homocysteine Levels and the Risk of Osteoporotic Fracture: A Systematic Review and Meta-Analysis
Osteoporosis InternationalSystematic review
- 20. Homocysteine and First Stroke in Hypertensive Adults Receiving Enalapril With or Without Folic Acid
StrokeRandomized trial
- 21. Maternal Homocysteine and Adverse Pregnancy Outcomes: Systematic Review and Meta-Analysis
Journal of Clinical MedicineSystematic review
- 22. Homocysteine: Function, Levels and Health Effects
Cleveland ClinicEvidence review
Editorial transparency
- Published by
- LongevityMate Editorial
- Editorial review by
- Lukas Dvorsky, Founder of LongevityMate
- Published
- Updated
Medical disclaimer
Educational information only, not a diagnosis, emergency service, cardiovascular or pregnancy-risk calculator, supplement prescription or personal treatment target. Use the reporting laboratory's context and a qualified clinician for individual decisions.
